FourThought Financial’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$13K Buy
158
+98
+163% +$9.24K ﹤0.01% 964
2022
Q2
$6K Hold
60
﹤0.01% 1123
2022
Q1
$9K Hold
60
﹤0.01% 1055
2021
Q4
$9K Sell
60
-68
-53% -$9.63K ﹤0.01% 1086
2021
Q3
$16K Hold
128
﹤0.01% 995
2021
Q2
$17K Hold
128
﹤0.01% 980
2021
Q1
$16K Sell
128
-16
-11% -$1.93K ﹤0.01% 945
2020
Q4
$16K Buy
+144
New +$13.6K ﹤0.01% 921

Other funds holding CNMD

FourThought Financial's CNMD Position: Q3 2022 in Review

FourThought Financial increased its CONMED (CNMD) stake by 163% in Q3 2022, buying an estimated $9.24K and bringing the position to 158 shares worth $13K. The position accounts for ﹤0.01% of the portfolio, ranked #964.

FourThought Financial first reported a position in CNMD in Q4 2020 and has held it in 8 quarters since. The position peaked at $17K in Q2 2021. 252 funds tracked by Wall St. Rank hold CNMD as of Q3 2022.

  • FourThought Financial held 158 shares of CONMED worth $13K as of Q3 2022.
  • FourThought Financial bought 98 CONMED shares in Q3 2022, an estimated $9.24K.
  • CONMED made up ﹤0.01% of FourThought Financial's portfolio in Q3 2022, its #964 holding.
  • FourThought Financial first reported a position in CONMED in Q4 2020 and has held it in 8 quarters since.
  • FourThought Financial's CONMED position peaked at $17K in Q2 2021.
  • 252 funds tracked by Wall St. Rank held CONMED as of Q3 2022.

Based on FourThought Financial's 13F filing for Q3 2022, filed 21 Nov 2022.